K-V Pharmaceutical Co 4

4 · K-V Pharmaceutical Co · Filed Sep 27, 2013

Form 4

Period: 2013-09-16

Director

Transactions

Other
Option to Purchase
2013-09-16−20,000→ 0 total
Exercise: $0.94Exp: 2022-05-14→ Class A Common Stock (20,000 underlying)
Other
Option to Purchase
2013-09-16−10,000→ 0 total
Exercise: $1.62Exp: 2020-09-07→ Class A Common Stock (10,000 underlying)
Other
Option to Purchase
2013-09-16−20,000→ 0 total
Exercise: $1.49Exp: 2021-09-08→ Class A Common Stock (20,000 underlying)
Other
Option to Purchase
2013-09-16−7,500→ 0 total
Exercise: $1.14Exp: 2020-05-24→ Class A Common Stock (7,500 underlying)

Footnotes (5)

[F1]On September 16, 2013, the Sixth Amended Joint Chapter 11 Plan of Reorganization of K-V Pharmaceutical Company (the "Company"), which was confirmed by the United States Bankruptcy Court for the Southern District of New York on August 28, 2013, was consummated. As a result, all issued and outstanding shares of the Companys Class A Common Stock, Class B Common Stock and 7% Cumulative Convertible Preferred Stock, and the warrants and options exercisable therefor, were cancelled and extinguished.
[F2]The option was to vest in five equal annual installments beginning on September 7, 2011.
[F3]The option was to vest in five equal installments beginning on June 24, 2011.
[F4]The option was to vest in three equal installments beginning on September 8, 2012.
[F5]The option was to vest 33% on May 14, 2013, 33% on May 14, 2014 and 34% on May 14, 2015.

Documents

1 file